AULGX
Price
$99.96
Change
-$3.41 (-3.30%)
Updated
Dec 18 closing price
GFACX
Price
$64.14
Change
-$8.99 (-12.29%)
Updated
Dec 18 closing price
Ad is loading...

AULGX vs GFACX

Header iconAULGX vs GFACX Comparison
Open Charts AULGX vs GFACXBanner chart's image
American Century Ultra® R5
Price$99.96
Change-$3.41 (-3.30%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer C
Price$64.14
Change-$8.99 (-12.29%)
VolumeN/A
CapitalizationN/A
AULGX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AULGX vs. GFACX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AULGX is a StrongBuy and GFACX is a Buy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 313B vs. AULGX (26.7B). AULGX (0.00) and GFACX (0.00) have matching dividends . AULGX was incepted earlier than GFACX: AULGX (8 years) vs GFACX (24 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. AULGX (20.00). AULGX has a lower initial minimum investment than GFACX: AULGX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 34.28 vs. AULGX (23.97). AULGX return over 5 years is better than : 91.60 vs. GFACX (47.11).
AULGXGFACXAULGX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years24 years-
Gain YTD30.55132.96493%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets26.7B313B9%
Annual Yield % from dividends0.000.00-
Returns for 1 year23.9734.2870%
Returns for 3 years16.0214.71109%
Returns for 5 years91.6047.11194%
Returns for 10 yearsN/A79.77-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FORA2.040.04
+2.00%
Forian
MPLN7.070.03
+0.43%
MultiPlan Corporation
SPNT15.14-0.43
-2.76%
SiriusPoint Ltd
JEF79.19-2.56
-3.13%
Jefferies Financial Group
NBY0.54-0.03
-4.86%
NovaBay Pharmaceuticals